Narayana Hrudayalaya: Business Overview & Financial Analysis
Narayana Hrudayalaya Limited is an Indian healthcare service provider headquartered in Bengaluru, Karnataka. Promoted by Dr. Devi Prasad Shetty, the company operates a network of multispecialty and super-specialty hospitals, heart centers, and primary care clinics across India and international markets, including the Cayman Islands and the United Kingdom. Operating through its primary brand "Narayana Health", the enterprise provides tertiary and quaternary medical care, with core specialisations in cardiac sciences, oncology, GI sciences, renal care, and organ transplants.
Healthcare Facility Portfolio & Bed Capacity of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya manages an international healthcare delivery network across owned units, operated facilities, and heart centers.
- India Facilities – 18 owned/operated hospitals, 2 heart centers, and 20 clinics
- International Facilities – 2 hospitals in Health City Cayman Islands and Practice Plus Group Hospitals in the UK
- Total Operating Healthcare Facilities – 42 units globally
- Total Operational Beds Capacity – 5,554 beds
The company operates 5,554 operational beds across India, the Caribbean, and the United Kingdom. Indian facilities form the core bed infrastructure, while international operations in Cayman Islands and the UK provide high-realisation medical and surgical revenue.
Speciality Revenue Mix of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya generates inpatient revenue across diverse clinical specialisations led by cardiac sciences.
- Cardiac Sciences – 33% of Total Inpatient Revenue
- Oncology – 15% of Total Inpatient Revenue
- Medicine & GI Sciences – 14% of Total Inpatient Revenue
- Renal Sciences – 9% of Total Inpatient Revenue
- Neurosciences – 7% of Total Inpatient Revenue
- Orthopedics – 4% of Total Inpatient Revenue
- Other Specialities (Pulmonology, ENT, Pediatrics) – 16% of Total Inpatient Revenue
Cardiac sciences represent the single largest clinical contributor, delivering complex adult and pediatric cardiovascular surgeries. Oncology and GI sciences function as secondary growth pillars, supported by linear accelerator radiation suites and robotic surgical systems.
Geographic Revenue Mix of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya derives its domestic operational revenue across established healthcare clusters in Southern and Eastern India.
- Bengaluru Metro Cluster – 36% of Domestic Revenue
- Kolkata Metro Cluster – 26% of Domestic Revenue
- Northern India Cluster – 13% of Domestic Revenue
- Eastern Peripheral Cluster (Jamshedpur, Guwahati) – 10% of Domestic Revenue
- Southern Peripheral Cluster (Mysore, Shimoga) – 10% of Domestic Revenue
- Western India Cluster – 5% of Domestic Revenue
Bengaluru and Kolkata metro hubs contribute 62% of domestic revenue, anchored by flagship health cities. Regional peripheral facilities in Tier-2 and Tier-3 towns act as feeder networks for tertiary surgical procedures at core metro hospitals.
Business Model & Payor Mix of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya operates owned and leased hospital models while maintaining a diversified patient payor profile.
- Owned & Leased Hospital Share – 73% of Domestic AUM/Revenue
- Operated & Managed Hospital Share – 25% of Domestic Revenue
- Heart Centres Sourcing Share – 2% of Domestic Revenue
- Domestic Walk-in Cash Patients – 47% of Payor Mix
- Insured & Corporate Patients – 31% of Payor Mix
- Government Healthcare Schemes – 18% of Payor Mix
- International Inbound Patients – 4% of Payor Mix
Direct cash-paying walk-in patients account for 47% of total payor volume, ensuring low receivables holding periods. Private insurance and corporate tie-ups comprise 31%, while government subsidised schemes represent 18% of total volume.
Operational KPIs & Hospital Metrics of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya tracks inpatient length of stay, bed occupancies, and patient realisations across domestic units.
- Average Revenue Per Occupied Bed (ARPOB - India) – Rs 39,200 per day
- Average Length of Stay (ALOS) – 4.3 days
- Outpatient Footfalls – 662,000 visits
- ICU Occupied Bed Days – 96,000 bed days
- Inpatient Discharges – 62,400 patients
Domestic ARPOB reached Rs 39,200 per day in Q3 FY26, supported by complex surgical cases and oncology procedures. Average length of stay held at 4.3 days, optimising bed turnover rates across critical care units.
International Operations Performance of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya operates international healthcare and insurance assets in the Cayman Islands and the United Kingdom.
- Cayman Islands Hospital Revenue – $41.6 million
- Cayman Health Insurance Revenue – $9.3 million
- Cayman Outpatient Footfalls – 12,301 patients
- Cayman Total Inpatient Discharges – 785 patients
Operations in the Cayman Islands delivered $41.6 million in quarterly hospital turnover, supplemented by $9.3 million from captive health insurance plans. The Cayman business generates significantly higher ARPOB than domestic Indian units.
Latest Quarterly Financial Performance of Narayana Hrudayalaya (Q3 FY26)
Narayana Hrudayalaya recorded top-line growth and operating profit expansion during the third quarter of FY26.
- Consolidated Revenue from Operations – Rs 1,398.20 crore (+12.4% YoY)
- Consolidated Operating EBITDA – Rs 318.50 crore (+10.8% YoY)
- Operating EBITDA Margin – 22.8% (-30 bps YoY)
- Consolidated Net Profit After Tax (PAT) – Rs 192.40 crore (+14.2% YoY)
- Domestic Business EBITDA Margin – 20.2%
Quarterly revenue from operations expanded 12.4% year-on-year to Rs 1,398.20 crore in Q3 FY26, supported by patient volume growth in Bengaluru and Cayman Islands. Consolidated Net Profit After Tax rose 14.2% to Rs 192.40 crore.
Capex Pipeline & Capacity Expansion Roadmap of Narayana Hrudayalaya (FY26–FY30)
Narayana Hrudayalaya executes greenfield and brownfield hospital expansions to scale total operational capacity to 7,600+ beds.
- Current Operating Capacity – 5,750 beds
- Target Capacity (by FY30) – 7,600+ operational beds
- HSR Layout Greenfield Facility (Bengaluru) – 215 beds (Outlay: Rs 490 crore; Expected Completion: FY28)
- Rajarhat Greenfield Facility (Kolkata) – 350 beds (Outlay: Rs 900 crore; Expected Completion: FY28)
- Central Bengaluru Unit – 220 beds (Outlay: Rs 160 crore; Expected Completion: FY28)
- South Bengaluru Facility – 350 beds (Outlay: Rs 800 crore; Expected Completion: FY29)
- Raipur Unit Expansion – 300 beds (Outlay: Rs 540 crore; Expected Completion: FY28)
- South-West Bengaluru Lease Expansion – 100 beds (Outlay: Rs 84 crore; Expected Completion: FY27)
The company is deploying over Rs 2,900 crore across greenfield projects in Bengaluru, Kolkata, and Raipur to add ~1,850 beds by FY30. Project funding will rely on internal cash accruals and debt facilities raised through international subsidiaries.
Management Commentary & Future Outlook of Narayana Hrudayalaya (Q3 FY26)
Management guidance outlines strategic priorities centered on bed capacity expansion, UK market integration, and digital health scaling.
- Management targets scaling total operational bed capacity past 7,600 beds by FY30.
- UK market entry via Practice Plus Group Hospitals Limited acquisition will be integrated as a leveraged, debt-free purchase for the parent.
- Operating EBITDA margins for domestic operations are guided to sustain above 20.0%, backed by ARPOB improvement.
- NH Integrated Care and Insurance program will be expanded nationally across all major domestic hospital clusters.
- Annual capital expenditure for domestic greenfield projects is budgeted at Rs 700–800 crore over FY27–FY28.
Management projects clinical demand for complex tertiary care to drive inpatient ARPOB growth across India and the Cayman Islands. Strategic focus remains on executing the 1,850-bed expansion pipeline, integrating UK hospital acquisitions, and scaling captive health insurance products.
Want to filter out stocks using your own financial benchmarks? You can use the Stock Screener on Finology Ticker to identify and compare companies based on specific growth and efficiency metrics.
Sources & References
- Narayana Hrudayalaya Limited Q3 FY26 Unaudited Financial Results Disclosures (January 2026) [1]
- Narayana Hrudayalaya Limited Q3 FY26 Investor Presentation & Factsheet (January 2026) [2]
- Narayana Hrudayalaya Limited Q3 FY26 Earnings Call Transcript (January 2026) [3]
- BSE India & NSE Corporate Disclosures for Narayana Hrudayalaya Limited [1, 2]
- Ticker Finology Narayana Hrudayalaya Page
Disclaimer
The information presented above on Narayana Hrudayalaya Limited has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Narayana Hrudayalaya Limited page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.